MAZZANTINI, COSTANZA
 Distribuzione geografica
Continente #
EU - Europa 529
NA - Nord America 320
AS - Asia 133
AF - Africa 6
Totale 988
Nazione #
US - Stati Uniti d'America 320
RU - Federazione Russa 212
IT - Italia 91
PL - Polonia 90
IE - Irlanda 67
HK - Hong Kong 42
CN - Cina 36
SE - Svezia 31
SG - Singapore 27
CH - Svizzera 14
JO - Giordania 11
FI - Finlandia 10
IN - India 8
VN - Vietnam 6
GB - Regno Unito 5
CI - Costa d'Avorio 4
ES - Italia 2
FR - Francia 2
NL - Olanda 2
UA - Ucraina 2
DE - Germania 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
MG - Madagascar 1
ZA - Sudafrica 1
Totale 988
Città #
Warsaw 90
Dublin 65
Ashburn 37
Chandler 35
Fairfield 34
Hong Kong 30
Singapore 19
Woodbridge 19
Shanghai 17
Seattle 16
Bern 14
Florence 13
Houston 13
Altamura 12
Lawrence 12
Moscow 11
Cambridge 10
Wilmington 9
Buffalo 8
Princeton 8
Medford 7
Naples 7
Helsinki 6
Santa Clara 6
Turin 6
Ann Arbor 5
San Diego 5
Abidjan 4
Dong Ket 4
Kent 4
Mumbai 4
Norwalk 4
Rome 4
West Jordan 4
Chennai 3
Ferrara 3
Lappeenranta 3
Pescara 3
Beijing 2
Bologna 2
Cascina 2
Gorgonzola 2
Ivrea 2
Los Angeles 2
Madrid 2
Massa 2
Milan 2
New York 2
Paris 2
Pearsall 2
Pisa 2
Redmond 2
Sassuolo 2
Sermoneta 2
Antananarivo 1
Boardman 1
Boston 1
Brentford 1
Cape Town 1
Collecchio 1
Groningen 1
Guangzhou 1
Hangzhou 1
Hillsboro 1
Hounslow 1
Kilburn 1
Livorno 1
London 1
Lucca 1
Munich 1
Palermo 1
Phoenix 1
Pune 1
Sassari 1
Seoul 1
Sesto Fiorentino 1
Slough 1
Washington 1
Totale 610
Nome #
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 138
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 121
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 104
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 80
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 77
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 56
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 55
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 54
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 52
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 51
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 47
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 44
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 38
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 36
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 35
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 22
Totale 1.010
Categoria #
all - tutte 4.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 4 9 8 6 8 6 4 4 2
2020/2021142 5 12 0 15 34 14 6 6 17 12 7 14
2021/202268 0 0 1 0 1 10 19 2 3 4 17 11
2022/2023263 12 31 10 10 21 41 38 22 43 4 12 19
2023/2024189 3 17 25 11 16 14 13 41 4 15 16 14
2024/2025288 31 81 57 119 0 0 0 0 0 0 0 0
Totale 1.010